- Solutions
- Discovery and Development
- Research Models and Services
- Teklad™ Diet, Bedding and Enrichment
- Insights
- About
- Investors
CLOSE ×
Inotiv Blog
![Inotiv](https://blog.inotivco.com/hubfs/2022%20Website/inotiv-background.png)
![](https://blog.inotivco.com/hubfs/2022%20Website/Home/icon-elements-2023.png)
[topic, colitis]
https://blog.inotivco.com
colitis
[Safety Assessment, IBD, Crohn's, Colitis, Endoscopy]
![](https://blog.inotivco.com/hubfs/D0011-Not-All-IBD-Models-Are-Created-Equally-LP.png)
Advantages of Non-Remitting Chronic IBD Models
The Advantages of Non-Remitting Chronic IBD Rodent ModelsAs the frequency of inflammatory bowel disease (IBD) increases globally, preclinical researchers continue to study new treatments that can...